2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

MG Crespo‐Leiro, M Metra, LH Lund… - European journal of …, 2018 - Wiley Online Library
This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association

SL Chow, AS Maisel, I Anand, B Bozkurt, RA De Boer… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Established and emerging roles of biomarkers in heart failure

NE Ibrahim, JL Januzzi Jr - Circulation research, 2018 - Am Heart Assoc
Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction

A Aimo, HK Gaggin, A Barison, M Emdin, JL Januzzi - JACC: Heart Failure, 2019 - jacc.org
In response to injury, hemodynamic changes, or neurohormonal activation, the heart
undergoes a series of structural and functional changes that have been termed cardiac …

2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American …

CW Yancy, M Jessup, B Bozkurt, J Butler, DE Casey Jr… - Circulation, 2017 - Am Heart Assoc
The purpose of this focused update is to update the “2013 ACCF/AHA Guideline for the
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …

Heart failure with reduced ejection fraction

MW Bloom, B Greenberg, T Jaarsma… - Nature reviews Disease …, 2017 - nature.com
Heart failure is a global public health problem that affects more than 26 million people
worldwide. The global burden of heart failure is growing and is expected to increase …

Association between intraoperative hypotension and myocardial injury after vascular surgery

JAR Van Waes, WA Van Klei… - Survey of …, 2016 - journals.lww.com
Myocardial infarction remains a leading cause of postopera-tive complications and carries
the threat of an increased risk of mortality for those patients who experience it. It is believed …

sST2 predicts outcome in chronic heart failure beyond NT− proBNP and high-sensitivity troponin T

M Emdin, A Aimo, G Vergaro, A Bayes-Genis… - Journal of the American …, 2018 - jacc.org
Background: Soluble suppression of tumorigenesis-2 (sST2) is a biomarker related to
inflammation and fibrosis. Objectives: This study assessed the independent prognostic value …

Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week

A Aimo, JL Januzzi, A Bayes-Genis, G Vergaro… - Journal of the American …, 2019 - jacc.org
Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular
congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor …